世界の動脈硬化症治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Arteriosclerosis Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5086 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、動脈硬化症治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（内科、外科）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・動脈硬化症治療薬の市場動向 ・企業の競争状況、市場シェア ・動脈硬化症治療薬の種類別市場規模と予測2016-2027（内科、外科） ・動脈硬化症治療薬の用途別市場規模と予測2016-2027（病院、診療所、その他） ・動脈硬化症治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・動脈硬化症治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・動脈硬化症治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・動脈硬化症治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・動脈硬化症治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（AstraZeneca、Pfizer、Bayer、Merck、Novartis、Sanofi、Hoffmann-La Roche、GlaxoSmithKline、Isis Pharmaceuticals、Anthera Pharmaceuticals、Johnson and Johnson、Cardium Therapeutics） ・結論

Arteriosclerosis is a generalized thickening and stiffening of the arterial wall and is related to high blood pressure or hypertension.

Market Analysis and Insights: Global Arteriosclerosis Therapeutics Market
The global Arteriosclerosis Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Arteriosclerosis Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Arteriosclerosis Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Arteriosclerosis Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Arteriosclerosis Therapeutics market.

Global Arteriosclerosis Therapeutics Scope and Market Size
Arteriosclerosis Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Arteriosclerosis Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Medicine
Surgery

Segment by Application
Hospital
Clinic
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AstraZeneca
Pfizer
Bayer
Merck
Novartis
Sanofi
Hoffmann-La Roche
GlaxoSmithKline
Isis Pharmaceuticals
Anthera Pharmaceuticals
Johnson and Johnson
Cardium Therapeutics

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Arteriosclerosis Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Medicine
1.2.3 Surgery
1.3 Market by Application
1.3.1 Global Arteriosclerosis Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Arteriosclerosis Therapeutics Market Perspective (2016-2027)
2.2 Arteriosclerosis Therapeutics Growth Trends by Regions
2.2.1 Arteriosclerosis Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Arteriosclerosis Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Arteriosclerosis Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Arteriosclerosis Therapeutics Industry Dynamic
2.3.1 Arteriosclerosis Therapeutics Market Trends
2.3.2 Arteriosclerosis Therapeutics Market Drivers
2.3.3 Arteriosclerosis Therapeutics Market Challenges
2.3.4 Arteriosclerosis Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Arteriosclerosis Therapeutics Players by Revenue
3.1.1 Global Top Arteriosclerosis Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Arteriosclerosis Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Arteriosclerosis Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Arteriosclerosis Therapeutics Revenue
3.4 Global Arteriosclerosis Therapeutics Market Concentration Ratio
3.4.1 Global Arteriosclerosis Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Arteriosclerosis Therapeutics Revenue in 2020
3.5 Arteriosclerosis Therapeutics Key Players Head office and Area Served
3.6 Key Players Arteriosclerosis Therapeutics Product Solution and Service
3.7 Date of Enter into Arteriosclerosis Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Arteriosclerosis Therapeutics Breakdown Data by Type
4.1 Global Arteriosclerosis Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Arteriosclerosis Therapeutics Forecasted Market Size by Type (2022-2027)

5 Arteriosclerosis Therapeutics Breakdown Data by Application
5.1 Global Arteriosclerosis Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Arteriosclerosis Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Arteriosclerosis Therapeutics Market Size (2016-2027)
6.2 North America Arteriosclerosis Therapeutics Market Size by Type
6.2.1 North America Arteriosclerosis Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Arteriosclerosis Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Arteriosclerosis Therapeutics Market Size by Type (2016-2027)
6.3 North America Arteriosclerosis Therapeutics Market Size by Application
6.3.1 North America Arteriosclerosis Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Arteriosclerosis Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Arteriosclerosis Therapeutics Market Size by Application (2016-2027)
6.4 North America Arteriosclerosis Therapeutics Market Size by Country
6.4.1 North America Arteriosclerosis Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Arteriosclerosis Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Arteriosclerosis Therapeutics Market Size (2016-2027)
7.2 Europe Arteriosclerosis Therapeutics Market Size by Type
7.2.1 Europe Arteriosclerosis Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Arteriosclerosis Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Arteriosclerosis Therapeutics Market Size by Type (2016-2027)
7.3 Europe Arteriosclerosis Therapeutics Market Size by Application
7.3.1 Europe Arteriosclerosis Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Arteriosclerosis Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Arteriosclerosis Therapeutics Market Size by Application (2016-2027)
7.4 Europe Arteriosclerosis Therapeutics Market Size by Country
7.4.1 Europe Arteriosclerosis Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Arteriosclerosis Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Arteriosclerosis Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Arteriosclerosis Therapeutics Market Size by Type
8.2.1 Asia-Pacific Arteriosclerosis Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Arteriosclerosis Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Arteriosclerosis Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Arteriosclerosis Therapeutics Market Size by Application
8.3.1 Asia-Pacific Arteriosclerosis Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Arteriosclerosis Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Arteriosclerosis Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Arteriosclerosis Therapeutics Market Size by Region
8.4.1 Asia-Pacific Arteriosclerosis Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Arteriosclerosis Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Arteriosclerosis Therapeutics Market Size (2016-2027)
9.2 Latin America Arteriosclerosis Therapeutics Market Size by Type
9.2.1 Latin America Arteriosclerosis Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Arteriosclerosis Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Arteriosclerosis Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Arteriosclerosis Therapeutics Market Size by Application
9.3.1 Latin America Arteriosclerosis Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Arteriosclerosis Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Arteriosclerosis Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Arteriosclerosis Therapeutics Market Size by Country
9.4.1 Latin America Arteriosclerosis Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Arteriosclerosis Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Arteriosclerosis Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Arteriosclerosis Therapeutics Market Size by Type
10.2.1 Middle East & Africa Arteriosclerosis Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Arteriosclerosis Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Arteriosclerosis Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Arteriosclerosis Therapeutics Market Size by Application
10.3.1 Middle East & Africa Arteriosclerosis Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Arteriosclerosis Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Arteriosclerosis Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Arteriosclerosis Therapeutics Market Size by Country
10.4.1 Middle East & Africa Arteriosclerosis Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Arteriosclerosis Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Arteriosclerosis Therapeutics Introduction
11.1.4 AstraZeneca Revenue in Arteriosclerosis Therapeutics Business (2016-2021)
11.1.5 AstraZeneca Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Arteriosclerosis Therapeutics Introduction
11.2.4 Pfizer Revenue in Arteriosclerosis Therapeutics Business (2016-2021)
11.2.5 Pfizer Recent Development
11.3 Bayer
11.3.1 Bayer Company Details
11.3.2 Bayer Business Overview
11.3.3 Bayer Arteriosclerosis Therapeutics Introduction
11.3.4 Bayer Revenue in Arteriosclerosis Therapeutics Business (2016-2021)
11.3.5 Bayer Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Arteriosclerosis Therapeutics Introduction
11.4.4 Merck Revenue in Arteriosclerosis Therapeutics Business (2016-2021)
11.4.5 Merck Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Arteriosclerosis Therapeutics Introduction
11.5.4 Novartis Revenue in Arteriosclerosis Therapeutics Business (2016-2021)
11.5.5 Novartis Recent Development
11.6 Sanofi
11.6.1 Sanofi Company Details
11.6.2 Sanofi Business Overview
11.6.3 Sanofi Arteriosclerosis Therapeutics Introduction
11.6.4 Sanofi Revenue in Arteriosclerosis Therapeutics Business (2016-2021)
11.6.5 Sanofi Recent Development
11.7 Hoffmann-La Roche
11.7.1 Hoffmann-La Roche Company Details
11.7.2 Hoffmann-La Roche Business Overview
11.7.3 Hoffmann-La Roche Arteriosclerosis Therapeutics Introduction
11.7.4 Hoffmann-La Roche Revenue in Arteriosclerosis Therapeutics Business (2016-2021)
11.7.5 Hoffmann-La Roche Recent Development
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Company Details
11.8.2 GlaxoSmithKline Business Overview
11.8.3 GlaxoSmithKline Arteriosclerosis Therapeutics Introduction
11.8.4 GlaxoSmithKline Revenue in Arteriosclerosis Therapeutics Business (2016-2021)
11.8.5 GlaxoSmithKline Recent Development
11.9 Isis Pharmaceuticals
11.9.1 Isis Pharmaceuticals Company Details
11.9.2 Isis Pharmaceuticals Business Overview
11.9.3 Isis Pharmaceuticals Arteriosclerosis Therapeutics Introduction
11.9.4 Isis Pharmaceuticals Revenue in Arteriosclerosis Therapeutics Business (2016-2021)
11.9.5 Isis Pharmaceuticals Recent Development
11.10 Anthera Pharmaceuticals
11.10.1 Anthera Pharmaceuticals Company Details
11.10.2 Anthera Pharmaceuticals Business Overview
11.10.3 Anthera Pharmaceuticals Arteriosclerosis Therapeutics Introduction
11.10.4 Anthera Pharmaceuticals Revenue in Arteriosclerosis Therapeutics Business (2016-2021)
11.10.5 Anthera Pharmaceuticals Recent Development
11.11 Johnson and Johnson
11.11.1 Johnson and Johnson Company Details
11.11.2 Johnson and Johnson Business Overview
11.11.3 Johnson and Johnson Arteriosclerosis Therapeutics Introduction
11.11.4 Johnson and Johnson Revenue in Arteriosclerosis Therapeutics Business (2016-2021)
11.11.5 Johnson and Johnson Recent Development
11.12 Cardium Therapeutics
11.12.1 Cardium Therapeutics Company Details
11.12.2 Cardium Therapeutics Business Overview
11.12.3 Cardium Therapeutics Arteriosclerosis Therapeutics Introduction
11.12.4 Cardium Therapeutics Revenue in Arteriosclerosis Therapeutics Business (2016-2021)
11.12.5 Cardium Therapeutics Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Arteriosclerosis Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Medicine
Table 3. Key Players of Surgery
Table 4. Global Arteriosclerosis Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Arteriosclerosis Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Arteriosclerosis Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Arteriosclerosis Therapeutics Market Share by Regions (2016-2021)
Table 8. Global Arteriosclerosis Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Arteriosclerosis Therapeutics Market Share by Regions (2022-2027)
Table 10. Arteriosclerosis Therapeutics Market Trends
Table 11. Arteriosclerosis Therapeutics Market Drivers
Table 12. Arteriosclerosis Therapeutics Market Challenges
Table 13. Arteriosclerosis Therapeutics Market Restraints
Table 14. Global Arteriosclerosis Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Arteriosclerosis Therapeutics Market Share by Players (2016-2021)
Table 16. Global Top Arteriosclerosis Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Arteriosclerosis Therapeutics as of 2020)
Table 17. Ranking of Global Top Arteriosclerosis Therapeutics Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Arteriosclerosis Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Arteriosclerosis Therapeutics Product Solution and Service
Table 21. Date of Enter into Arteriosclerosis Therapeutics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Arteriosclerosis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Arteriosclerosis Therapeutics Revenue Market Share by Type (2016-2021)
Table 25. Global Arteriosclerosis Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Arteriosclerosis Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Arteriosclerosis Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Arteriosclerosis Therapeutics Revenue Market Share by Application (2016-2021)
Table 29. Global Arteriosclerosis Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Arteriosclerosis Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Arteriosclerosis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Arteriosclerosis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Arteriosclerosis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Arteriosclerosis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Arteriosclerosis Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Arteriosclerosis Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Arteriosclerosis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Arteriosclerosis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Arteriosclerosis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Arteriosclerosis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Arteriosclerosis Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Arteriosclerosis Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Arteriosclerosis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Arteriosclerosis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Arteriosclerosis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Arteriosclerosis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Arteriosclerosis Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Arteriosclerosis Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Arteriosclerosis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Arteriosclerosis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Arteriosclerosis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Arteriosclerosis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Arteriosclerosis Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Arteriosclerosis Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Arteriosclerosis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Arteriosclerosis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Arteriosclerosis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Arteriosclerosis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Arteriosclerosis Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Arteriosclerosis Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 61. AstraZeneca Company Details
Table 62. AstraZeneca Business Overview
Table 63. AstraZeneca Arteriosclerosis Therapeutics Product
Table 64. AstraZeneca Revenue in Arteriosclerosis Therapeutics Business (2016-2021) & (US$ Million)
Table 65. AstraZeneca Recent Development
Table 66. Pfizer Company Details
Table 67. Pfizer Business Overview
Table 68. Pfizer Arteriosclerosis Therapeutics Product
Table 69. Pfizer Revenue in Arteriosclerosis Therapeutics Business (2016-2021) & (US$ Million)
Table 70. Pfizer Recent Development
Table 71. Bayer Company Details
Table 72. Bayer Business Overview
Table 73. Bayer Arteriosclerosis Therapeutics Product
Table 74. Bayer Revenue in Arteriosclerosis Therapeutics Business (2016-2021) & (US$ Million)
Table 75. Bayer Recent Development
Table 76. Merck Company Details
Table 77. Merck Business Overview
Table 78. Merck Arteriosclerosis Therapeutics Product
Table 79. Merck Revenue in Arteriosclerosis Therapeutics Business (2016-2021) & (US$ Million)
Table 80. Merck Recent Development
Table 81. Novartis Company Details
Table 82. Novartis Business Overview
Table 83. Novartis Arteriosclerosis Therapeutics Product
Table 84. Novartis Revenue in Arteriosclerosis Therapeutics Business (2016-2021) & (US$ Million)
Table 85. Novartis Recent Development
Table 86. Sanofi Company Details
Table 87. Sanofi Business Overview
Table 88. Sanofi Arteriosclerosis Therapeutics Product
Table 89. Sanofi Revenue in Arteriosclerosis Therapeutics Business (2016-2021) & (US$ Million)
Table 90. Sanofi Recent Development
Table 91. Hoffmann-La Roche Company Details
Table 92. Hoffmann-La Roche Business Overview
Table 93. Hoffmann-La Roche Arteriosclerosis Therapeutics Product
Table 94. Hoffmann-La Roche Revenue in Arteriosclerosis Therapeutics Business (2016-2021) & (US$ Million)
Table 95. Hoffmann-La Roche Recent Development
Table 96. GlaxoSmithKline Company Details
Table 97. GlaxoSmithKline Business Overview
Table 98. GlaxoSmithKline Revenue in Arteriosclerosis Therapeutics Business (2016-2021) & (US$ Million)
Table 99. GlaxoSmithKline Recent Development
Table 100. Isis Pharmaceuticals Company Details
Table 101. Isis Pharmaceuticals Business Overview
Table 102. Isis Pharmaceuticals Arteriosclerosis Therapeutics Product
Table 103. Isis Pharmaceuticals Revenue in Arteriosclerosis Therapeutics Business (2016-2021) & (US$ Million)
Table 104. Isis Pharmaceuticals Recent Development
Table 105. Anthera Pharmaceuticals Company Details
Table 106. Anthera Pharmaceuticals Business Overview
Table 107. Anthera Pharmaceuticals Arteriosclerosis Therapeutics Product
Table 108. Anthera Pharmaceuticals Revenue in Arteriosclerosis Therapeutics Business (2016-2021) & (US$ Million)
Table 109. Anthera Pharmaceuticals Recent Development
Table 110. Johnson and Johnson Company Details
Table 111. Johnson and Johnson Business Overview
Table 112. Johnson and Johnson Arteriosclerosis Therapeutics Product
Table 113. Johnson and Johnson Revenue in Arteriosclerosis Therapeutics Business (2016-2021) & (US$ Million)
Table 114. Johnson and Johnson Recent Development
Table 115. Cardium Therapeutics Company Details
Table 116. Cardium Therapeutics Business Overview
Table 117. Cardium Therapeutics Arteriosclerosis Therapeutics Product
Table 118. Cardium Therapeutics Revenue in Arteriosclerosis Therapeutics Business (2016-2021) & (US$ Million)
Table 119. Cardium Therapeutics Recent Development
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Arteriosclerosis Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Medicine Features
Figure 3. Surgery Features
Figure 4. Global Arteriosclerosis Therapeutics Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Other Case Studies
Figure 8. Arteriosclerosis Therapeutics Report Years Considered
Figure 9. Global Arteriosclerosis Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Arteriosclerosis Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Arteriosclerosis Therapeutics Market Share by Regions: 2020 VS 2027
Figure 12. Global Arteriosclerosis Therapeutics Market Share by Regions (2022-2027)
Figure 13. Global Arteriosclerosis Therapeutics Market Share by Players in 2020
Figure 14. Global Top Arteriosclerosis Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Arteriosclerosis Therapeutics as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Arteriosclerosis Therapeutics Revenue in 2020
Figure 16. Global Arteriosclerosis Therapeutics Revenue Market Share by Type (2016-2021)
Figure 17. Global Arteriosclerosis Therapeutics Revenue Market Share by Type (2022-2027)
Figure 18. North America Arteriosclerosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Arteriosclerosis Therapeutics Market Share by Type (2016-2027)
Figure 20. North America Arteriosclerosis Therapeutics Market Share by Application (2016-2027)
Figure 21. North America Arteriosclerosis Therapeutics Market Share by Country (2016-2027)
Figure 22. United States Arteriosclerosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Arteriosclerosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Arteriosclerosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Arteriosclerosis Therapeutics Market Share by Type (2016-2027)
Figure 26. Europe Arteriosclerosis Therapeutics Market Share by Application (2016-2027)
Figure 27. Europe Arteriosclerosis Therapeutics Market Share by Country (2016-2027)
Figure 28. Germany Arteriosclerosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Arteriosclerosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Arteriosclerosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Arteriosclerosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Arteriosclerosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Arteriosclerosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Arteriosclerosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Arteriosclerosis Therapeutics Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Arteriosclerosis Therapeutics Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Arteriosclerosis Therapeutics Market Share by Region (2016-2027)
Figure 38. China Arteriosclerosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Arteriosclerosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Arteriosclerosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Arteriosclerosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Arteriosclerosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Arteriosclerosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Arteriosclerosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Arteriosclerosis Therapeutics Market Share by Type (2016-2027)
Figure 46. Latin America Arteriosclerosis Therapeutics Market Share by Application (2016-2027)
Figure 47. Latin America Arteriosclerosis Therapeutics Market Share by Country (2016-2027)
Figure 48. Mexico Arteriosclerosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Arteriosclerosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Arteriosclerosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Arteriosclerosis Therapeutics Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Arteriosclerosis Therapeutics Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Arteriosclerosis Therapeutics Market Share by Country (2016-2027)
Figure 54. Turkey Arteriosclerosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Arteriosclerosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Arteriosclerosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. AstraZeneca Revenue Growth Rate in Arteriosclerosis Therapeutics Business (2016-2021)
Figure 58. Pfizer Revenue Growth Rate in Arteriosclerosis Therapeutics Business (2016-2021)
Figure 59. Bayer Revenue Growth Rate in Arteriosclerosis Therapeutics Business (2016-2021)
Figure 60. Merck Revenue Growth Rate in Arteriosclerosis Therapeutics Business (2016-2021)
Figure 61. Novartis Revenue Growth Rate in Arteriosclerosis Therapeutics Business (2016-2021)
Figure 62. Sanofi Revenue Growth Rate in Arteriosclerosis Therapeutics Business (2016-2021)
Figure 63. Hoffmann-La Roche Revenue Growth Rate in Arteriosclerosis Therapeutics Business (2016-2021)
Figure 64. GlaxoSmithKline Revenue Growth Rate in Arteriosclerosis Therapeutics Business (2016-2021)
Figure 65. Isis Pharmaceuticals Revenue Growth Rate in Arteriosclerosis Therapeutics Business (2016-2021)
Figure 66. Anthera Pharmaceuticals Revenue Growth Rate in Arteriosclerosis Therapeutics Business (2016-2021)
Figure 67. Johnson and Johnson Revenue Growth Rate in Arteriosclerosis Therapeutics Business (2016-2021)
Figure 68. Cardium Therapeutics Revenue Growth Rate in Arteriosclerosis Therapeutics Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

---